A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
167/193
A61K 31/56 (2006.01)
Patent
CA 1083963
USE OF FLUNISOLIDE TO TREAT RESPIRATORY DISEASES Abstract of The Disclosure Flunisolide, 6.alpha.-fluoro-11.beta.,21-dihydroxy-16.alpha.,17.alpha.-isopropyli- denedioxypregna-1,4-diene-3,20-dione, is administered by inhala- tion in a therapeutically effective dosage to a person having a respiratory disease such as bronchial asthma and allergic rhinitis. A unique crystalline polymorphic form of flunisolide is prepared by contacting one of the other polymorphic forms o solid flunisolide with a suitable liquid in which flunisolide has substantially no solubility, especially Freon? 12 or Freon? 114 or by recrystallizlng the unique crystalline form from a suitable solvent such as methylene chloride. The unique crystalline form is stable in aerosols such as Freon? mixtures and is valuable in the treatment of respiratory diseases.
332220
Fried John H.
Haringer Gisela T.
Jones Richard E.
Johnson Douglas S. Q.c.
Syntex (u.s.a.) Llc.
LandOfFree
Use of flunisolide to treat respiratory diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of flunisolide to treat respiratory diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of flunisolide to treat respiratory diseases will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1152455